Zobrazeno 1 - 10
of 11 938
pro vyhledávání: '"A. Cerrato"'
Autor:
Köppel, Marius, Witzig, Niklas, Klausmann, Tim, Cerrato, Mattia, Schweitzer, Tobias, Weber, Jochen, Yilmaz, Erdem, Chimbo, Juan, del Campo, Bernardo, Davila, Lissete, Barreno, David
The global Biochar Industry has witnessed a surge in biochar production, with a total of 350k mt/year production in 2023. With the pressing climate goals set and the potential of Biochar Carbon Removal (BCR) as a climate-relevant technology, scaling
Externí odkaz:
http://arxiv.org/abs/2412.07881
Autor:
Crane, Gregory, Tauber, James, Babeu, Alison, Cerrato, Lisa, Pletcher, Charles, Wulfman, Clifford, Kazmierski, Sergiusz, Shamsian, Farnoosh
We report here on the workflow that we needed to develop in order to integrate the growing range of openly licensed, born-digital and, increasingly, machine actionable publications. Our developmental work focused upon textual data for Ancient Greek,
Externí odkaz:
http://arxiv.org/abs/2411.10604
Fair Representation Learning (FRL) is a broad set of techniques, mostly based on neural networks, that seeks to learn new representations of data in which sensitive or undesired information has been removed. Methodologically, FRL was pioneered by Ric
Externí odkaz:
http://arxiv.org/abs/2407.03834
Autor:
Sánchez, Pedro A., Cerrato, Antonio, Cerdà, Joan J., Bona-Cases, Carles, Sintes, Tomás, Massó, Joan
Using nonequilibrium computer simulations, we study the response of ferromagnetic nanofilaments, consisting of stabilized onedimensional chains of ferromagnetic nanoparticles, under external rotating magnetic fields. In difference with their analogou
Externí odkaz:
http://arxiv.org/abs/2405.16403
Adopting a statistical approach we study the degradation of entanglement of a quantum system under the action of an ensemble of randomly distributed Markovian noise. This enables us to address scenarios where only limited information is available on
Externí odkaz:
http://arxiv.org/abs/2404.03505
Publikováno v:
AAAI, vol. 38, no. 10, pp. 11766-11774, Mar. 2024
Peer learning is a novel high-level reinforcement learning framework for agents learning in groups. While standard reinforcement learning trains an individual agent in trial-and-error fashion, all on its own, peer learning addresses a related setting
Externí odkaz:
http://arxiv.org/abs/2312.09950
Autor:
Luis F. Bonilla Larrama, Cesar U. Alas-Pineda, Anahi G. Pacheco, Victoria S. Díaz-Cerrato, Karla P. Molinero Leiva
Publikováno v:
Radiology Case Reports, Vol 20, Iss 1, Pp 1-5 (2025)
This case report describes a 23-year-old male who was incidentally diagnosed with Caroli disease while investigating symptoms of recurrent upper quadrant pain and fever. Imagining studies, including magnetic resonance cholangiography revealed the “
Externí odkaz:
https://doaj.org/article/7eef96d1f10e42c19a750bca72529461
Autor:
Oliver N. Shipley, Ashley Nicoll, Robert M. Cerrato, Keith J. Dunton, Bradley J. Peterson, Matthew Sclafani, Charles Bangley, Matthew T. Balazik, Matthew Breece, Brianna V. Cahill, Dewayne A. Fox, Benjamin I. Gahagan, Jeff Kneebone, Farrah Leone, Maria Manz, Matthew Ogburn, William C. Post, Brittney Scannell, Michael G. Frisk
Publikováno v:
Animal Biotelemetry, Vol 12, Iss 1, Pp 1-14 (2024)
Abstract Rapid global expansion of offshore wind farms, tidal, and wave technologies signifies a new era of renewable energy development. While a promising means to combat the impacts of climate change, such developments necessitate fine-scale monito
Externí odkaz:
https://doaj.org/article/7a55f1c91c024e9c8d261676b85345f1
The paper surveys automated scientific discovery, from equation discovery and symbolic regression to autonomous discovery systems and agents. It discusses the individual approaches from a "big picture" perspective and in context, but also discusses o
Externí odkaz:
http://arxiv.org/abs/2305.02251
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 9, Iss 1, Pp 1-15 (2024)
Abstract Background Radiopharmaceuticals have been considered a special group of medicines in Europe since 1989. The use of radiopharmaceuticals that have marketing authorization should always be the first option in clinical use, however due to their
Externí odkaz:
https://doaj.org/article/0f519e2a35b5423a8b643748d59c5c17